Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ · Healthcare
Vertex Pharmaceuticals Incorporated Total Liabilities 2008–2025
Vertex Pharmaceuticals Incorporated annual total liabilities history from 2009 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Vertex Pharmaceuticals Incorporated total liabilities as of December 31, 2025: 6.98B, a 13.94% increase year-over-year.
- Vertex Pharmaceuticals Incorporated total liabilities for 2025 were 6.98B, a 13.94% increase from 2024.
- Vertex Pharmaceuticals Incorporated total liabilities for 2024 were 6.12B, a 18.91% increase from 2023.
- Vertex Pharmaceuticals Incorporated total liabilities for 2023 were 5.15B, a 21.51% increase from 2022.
- Vertex Pharmaceuticals Incorporated total liabilities for 2022 were 4.24B.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vertex Pharmaceuticals Incorporated Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $6,977 |
| 2024 | $6,124 |
| 2023 | $5,150 |
| 2022 | $4,238 |
| 2021 | $3,333 |
| 2020 | $3,065 |
| 2019 | $2,233 |
| 2018 | $1,811 |
| 2017 | $1,504 |
| 2016 | $1,559 |
| 2015 | $1,405 |
| 2014 | $1,238 |
| 2013 | $963 |
| 2012 | $1,525 |
| 2011 | $1,239 |
Vertex Pharmaceuticals Inc. Total Liabilities — FAQ
Vertex Pharmaceuticals Inc. (VRTX) total liabilities over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRTX's total liabilities history?
The chart and table above show Vertex Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.